RFA
IMNR

Reilly Financial Advisors’s IMMUNE RESPONSE CORPORATION-NEW IMNR Stock Holding History

Reilly Financial Advisors’s Portfolio IMNR Stock Details IMNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-132
Closed – – 1520
2015
Q3 		$0 Buy
+132
New – ﹤0.01% 1493

Reilly Financial Advisors's IMNR Position: Q4 2015 in Review

Reilly Financial Advisors sold out of IMMUNE RESPONSE CORPORATION-NEW (IMNR) in Q4 2015, closing a stake of 132 shares.

Reilly Financial Advisors first reported a position in IMNR in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 0 funds tracked by Wall St. Rank hold IMNR as of Q4 2015.

  • Reilly Financial Advisors reported no remaining IMMUNE RESPONSE CORPORATION-NEW position as of Q4 2015 after selling out during the quarter.
  • Reilly Financial Advisors sold 132 IMMUNE RESPONSE CORPORATION-NEW shares in Q4 2015.
  • Reilly Financial Advisors first reported a position in IMMUNE RESPONSE CORPORATION-NEW in Q3 2015 and held it in 1 quarter.
  • Reilly Financial Advisors's IMMUNE RESPONSE CORPORATION-NEW position peaked at $0 in Q3 2015.
  • 0 funds tracked by Wall St. Rank held IMMUNE RESPONSE CORPORATION-NEW as of Q4 2015.

Based on Reilly Financial Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.